Quality by Design (QbD) for Development and Validation of Analytical Methods
View: 226
Website http://c2gowebinars.com/product/?topic=validation-analytical-methods |
Edit Freely
Category Houston
Deadline: June 15, 2016 | Date: June 15, 2016
Venue/Country: Online, U.S.A
Updated: 2016-05-07 15:13:19 (GMT+9)
Call For Papers - CFP
DESCRIPTIONUsing the QbD approach for development and validation will result in more robust analytical methods. Advantages are easier method transfer, longer revalidation cycles and fewer or no methods specific Out-of-Specification situations when used in routine. In addition, FDA, USP and international agencies promote the QbD approach because it is expected that such performance based routine methods can be changed within the analytical target profile (ATP) without regulatory resubmission and approval. Moreover, the new FDA Method Validation Guide suggests using QbD elements for development and validation. Because there is no or little experience with the QbD approach for analytical methods, the industry has many questions.Areas Covered in the Session:General principles and key benefits of QbDRegulatory background and trends: FDA, ICH Q8/9/10Reasons for changing the way we validate methodsCurrent applications of QbD in the pharmaceutical industryThe Application of QbD for analytical methodsComparison of the QbD process with ICH Q2 and USP Benefits for method transfer and routine useUsing the lifecycle approach for method design, development and validationDeveloping specifications and, the analytical target profileDocumenting input variables for risk assessment in fishbone diagramsUsing the risk assessment prioritization matrix to select the test parametersTraditional vs. the QbD process for method parameter optimizationThe method validation and qualification studiesUsing the method in the routine: on-going performance control, review and change controlContinuous monitoring and improvementsDocumentation requirementsDefining the Analytical Target Profile (ATP) and design space Case studiesWho will benefit QA managers and personnel Analysts and lab managersRegulatory affairsTraining departmentsMethod development departmentsDocumentation departmentConsultantsFrom Small, midsize and large Pharmaceutical companiesDevelopment API manufacturersContract laboratoriesClinical research organizationsMedical device industryFree HandoutsFor easy implementation, attendees will receive Master plan - Template and examples: Development and Validation of Analytical Methods through QbDSOP-Development and Validation of Analytical Methods through Quality by DesignChecklist :- Validation of Analytical Methods according to the FDA Guidance 2015Webinar includes:Q/A Session with the Expert to ask your questionPDF print only copy of PowerPoint slides75 Minutes Live PresentationCertificate of attendance
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.